Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 351,322 shares at $59.27 ($20.5M) on 2025-05-16, disclosed to the SEC on 2025-05-19.
Scheduled sale ($20.5M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.84 | 49,265 | $2.8M | 13.9% |
| 2 | $57.84 | 49,265 | $2.8M | 13.9% |
| 3 | $57.86 | 25,307 | $1.5M | 7.1% |
| 4 | $57.86 | 25,307 | $1.5M | 7.1% |
| 5 | $58.67 | 52,642 | $3.1M | 15.1% |
| 6 | $58.67 | 52,642 |
| $3.1M |
| 15.1% |
| 7 | $58.70 | 22,227 | $1.3M | 6.4% |
| 8 | $58.70 | 22,227 | $1.3M | 6.4% |
| 9 | $58.72 | 17,001 | $998K | 4.9% |
| 10 | $58.72 | 17,001 | $998K | 4.9% |
| 11 | $59.21 | 6,427 | $381K | 1.9% |
| 12 | $59.21 | 6,427 | $381K | 1.9% |
| 13 | $59.27 | 2,792 | $165K | 0.8% |
| 14 | $59.27 | 2,792 | $165K | 0.8% |
| Total | $58.36 avg | 351,322 | $20.5M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |